Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Autosomal recessive IL17RA deficiency underlies chronic mucocutaneous candidiasis (CMC) by abolishing IL-17 signaling and compromising mucocutaneous immunity.
IL17RA encodes the interleukin-17 receptor A, essential for IL-17A/F-mediated defense of the skin, nails, and mucosae. Homozygous loss-of-function variants in IL17RA cause autosomal recessive CMC, characterized by recurrent or persistent infections with Candida albicans and staphylococci in early life.
In a landmark study, 21 individuals from 12 unrelated kindreds harbored complete AR IL17RA deficiency across 12 distinct alleles, including eight upstream stop-gains and one missense allele (p.Asp387Asn), all abolishing receptor expression or function. All patients experienced first CMC episodes by 6 months, and 14 had staphylococcal skin disease (PMID:27930337).
A recent family report described four affected members of a consanguineous kindred presenting with CMC and staphylococcal skin lesions; homozygosity for IL17RA variants segregated with disease, and elevated IgG levels were documented (PMID:36866994).
A novel homozygous nonsense variant, c.787C>T (p.Arg263Ter), was identified in a 6-year-old male with refractory candidiasis and eczema; Sanger sequencing confirmed segregation, and flow cytometry revealed markedly reduced IL-17RA surface expression and impaired Th17 cell responses (PMID:37317577).
The variant spectrum spans splice-site (e.g., c.598+1G>T), frameshift (e.g., c.166_169dup (p.Cys57fs)), nonsense (e.g., c.787C>T (p.Arg263Ter)), and missense alleles, underscoring allelic heterogeneity and recurrent LoF mechanisms.
Functional assays in patient fibroblasts and leukocytes uniformly demonstrate abolished responses to IL-17A, IL-17F, and IL-25, confirming a loss-of-function disease mechanism (PMID:27930337, PMID:37317577).
Definitive evidence supports IL17RA as a causal gene for CMC, with robust genetic and experimental concordance. IL17RA sequencing should be included in diagnostic panels to guide targeted therapeutic interventions.
Gene–Disease AssociationDefinitive21 probands from unrelated kindreds (PMID:27930337) plus 4 affected family members (PMID:36866994), with consistent AR segregation and functional concordance Genetic EvidenceStrong
Functional EvidenceModerateFlow cytometry and in vitro assays show absent IL-17RA expression and abolished IL-17 responses (PMID:27930337, PMID:37317577) |